Free Trial

EUROFINS SCIENT (OTCMKTS:ERFSF) Stock Price Crosses Below 50 Day Moving Average - Should You Sell?

Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scient's share price has fallen below its 50-day moving average of $75.50, trading as low as $73.92 recently.
  • Analysts have a consensus rating of "Hold", with Citigroup reissuing a neutral rating and one analyst issuing a strong buy.
  • The company's debt-to-equity ratio stands at 0.77, indicating moderate financial leverage, while its current and quick ratios suggest solid short-term liquidity.
  • Five stocks to consider instead of Eurofins Scient.

Shares of EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report) crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $75.50 and traded as low as $73.92. EUROFINS SCIENT shares last traded at $76.99, with a volume of 1,183 shares.

Wall Street Analyst Weigh In

Separately, Citigroup reaffirmed a "neutral" rating on shares of EUROFINS SCIENT in a research note on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold".

View Our Latest Analysis on EUROFINS SCIENT

EUROFINS SCIENT Price Performance

The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19. The firm's 50-day simple moving average is $75.80 and its 200-day simple moving average is $66.43.

About EUROFINS SCIENT

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

See Also

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.